Boston Scientific (1BSX) Stock Statistics & Valuation Metrics
Total Valuation
Boston Scientific has a market cap or net worth of EUR 54.40B. The enterprise value is EUR 74.91B.
- Market Cap
- EUR 54.40B
- Enterprise Value
- EUR 74.91B
Share Statistics
Boston Scientific has 1,449,229,500 shares outstanding. The number of shares has decreased by -2.65% in one year.
- Shares Outstanding
- 1,449,229,500
- Owned by Insiders
- 0.16%
- Owned by Institutions
- 54.91%
Financial Efficiency
Boston Scientific’s return on equity (ROE) is 0.12 and return on invested capital (ROIC) is 8.78%.
- Return on Equity (ROE)
- 0.12
- Return on Assets (ROA)
- 0.07
- Return on Invested Capital (ROIC)
- 8.78%
- Return on Capital Employed (ROCE)
- 0.10
- Revenue Per Employee
- 340.24K
- Profits Per Employee
- 48.92K
- Employee Count
- 59,000
- Asset Turnover
- 0.46
- Inventory Turnover
- 2.11
Valuation Ratios
The current PE Ratio of Boston Scientific is 18.70. Boston Scientific’s PEG ratio is 0.74.
- PE Ratio
- 18.70
- PS Ratio
- 3.05
- PB Ratio
- 2.51
- Price to FCF
- 19.28
- Price to Operating Cash Flow
- 15.16
- PEG Ratio
- 0.74
Income Statement
In the last 12 months, Boston Scientific had revenue of 20.07B and earned 2.89B in profits. Earnings per share was 1.96.
- Revenue
- 20.07B
- Gross Profit
- 13.85B
- Operating Income
- 3.97B
- Pretax Income
- 3.38B
- Net Income
- 2.89B
- EBITDA
- 5.10B
- Earnings Per Share (EPS)
- 1.96
Cash Flow
In the last 12 months, operating cash flow was 4.53B and capital expenditures -904.00M, giving a free cash flow of 3.63B billion.
- Operating Cash Flow
- 4.53B
- Free Cash Flow
- 3.63B
- Free Cash Flow per Share
- 2.30
Dividends & Yields
Boston Scientific pays an annual dividend of ―, resulting in a dividend yield of ―
- Dividend Per Share
- ―
- Dividend Yield
- ―
- Payout Ratio
- N/A
- Free Cash Flow Yield
- 5.66%
- Earnings Yield
- 5.45%
Stock Price Statistics
- Beta
- 0.25
- 52-Week Price Change
- -55.37%
- 50-Day Moving Average
- 39.29
- 200-Day Moving Average
- 47.95
- Relative Strength Index (RSI)
- 49.40
- Average Volume (3m)
- 414
Important Dates
Boston Scientific upcoming earnings date is Feb 03, 2027, TBA (Not Confirmed).
- Last Earnings Date
- Oct 28, 2026
- Next Earnings Date
- Feb 03, 2027
- Ex-Dividend Date
- ―
Financial Position
Boston Scientific as a current ratio of 1.62, with Debt / Equity ratio of 51.24%
- Current Ratio
- 1.62
- Quick Ratio
- 1.08
- Debt to Market Cap
- 0.08
- Net Debt to EBITDA
- 2.03
- Interest Coverage Ratio
- 11.38
Taxes
In the past 12 months, Boston Scientific has paid 493.00M in taxes.
- Income Tax
- 493.00M
- Effective Tax Rate
- 0.15
Enterprise Valuation
Boston Scientific EV to EBITDA ratio is 14.07, with an EV/FCF ratio of 21.01.
- EV to Sales
- 3.61
- EV to EBITDA
- 14.07
- EV to Free Cash Flow
- 21.01
- EV to Operating Cash Flow
- 16.81
Balance Sheet
Boston Scientific has EUR 539.00M in cash and marketable securities with EUR 12.62B in debt, giving a net cash position of -EUR 12.09B billion.
- Cash & Marketable Securities
- EUR 539.00M
- Total Debt
- EUR 12.62B
- Net Cash
- -EUR 12.09B
- Net Cash Per Share
- -EUR 8.34
- Tangible Book Value Per Share
- -EUR 0.26
Margins
Gross margin is 70.37%, with operating margin of 21.05%, and net profit margin of 16.56%.
- Gross Margin
- 70.37%
- Operating Margin
- 21.05%
- Pretax Margin
- 17.35%
- Net Profit Margin
- 16.56%
- EBITDA Margin
- 25.70%
- EBIT Margin
- 20.61%
Analyst Forecast
The average price target for Boston Scientific is EUR 44.75, which is 11.43% higher than the current price. The consensus rating is Moderate Buy
- Price Target
- EUR 44.75
- Price Target Upside
- 14.72% Upside
- Analyst Consensus
- Moderate Buy
- Analyst Count
- 22
- Revenue Growth Forecast
- 3.60%
- EPS Growth Forecast
- 19.74%
Scores
- Smart Score
- 6
- AI Score
- ―
